Gut Bacteria Strain Cuts Lung Fibrosis by 30% in Aging Mice
A Lactobacillus strain found in centenarians reduced lung fibrosis scores by 30% and collagen by 40% in aging mice via the gut-lung axis.
Summary
Researchers discovered that a specific Lactobacillus gut bacteria strain, L9, can dramatically reduce age-related lung fibrosis in mice. Administered between 15 and 24 months of age, L9 cut total lung fibrosis scores by 30% and reduced collagen fibers by 40%. The bacteria works through the gut-lung axis, sending chemical signals into the bloodstream that suppress a long chain of inflammatory and molecular signals — including SASP-related cytokines — ultimately reducing the production of collagen protein Col-I by 59%. The strain was originally identified in centenarians and has previously shown benefits against allergies. This study adds pulmonary fibrosis to its list of potential therapeutic targets, suggesting gut microbiome interventions may one day help prevent or slow age-related lung decline.
Detailed Summary
Pulmonary fibrosis is a hallmark of aging, and until now most research has focused on the lungs themselves. A new study in Aging Cell shifts attention to the gut, revealing that a specific Lactobacillus strain called L9 — found in centenarians — can dramatically reduce lung fibrosis in aging mice by transmitting protective signals through the bloodstream via the gut-lung axis.
The researchers first confirmed that aging itself drives fibrosis. Both human lung samples and mouse data showed progressive collagen accumulation with age, with genes encoding extracellular matrix proteins significantly upregulated in older subjects. Mice at 24 months showed intense fibrosis compared to 15-month-old counterparts, validating the model.
When L9 was administered between 15 and 24 months, the results were striking. Total fibrosis scores dropped to 70% of controls. Collagen fibers fell by 40%, driven by a 59% reduction in the Col-I protein and a 61% drop in the collagen precursor PINP. The mechanism was traced to reduced collagen synthesis — not increased degradation — specifically through suppression of the molecular chaperone HSP47 and its transcription factor HSF1, downstream of the JNK signaling pathway.
The researchers traced the effect even further upstream to the senescence-associated secretory phenotype (SASP). Inflammatory cytokines IL-17A, IL-6, IL-1β, and TGFβ1 — classic SASP components — were all reduced, linking gut bacteria activity directly to the suppression of cellular senescence-driven inflammation in lung tissue.
While the findings are compelling, this remains a mouse study and has not yet been tested in humans. The precise metabolites L9 produces and how they cross into systemic circulation require further investigation. Still, the study offers a credible mechanistic pathway suggesting that targeted probiotic interventions could become a meaningful strategy for reducing age-related lung fibrosis and preserving respiratory healthspan.
Key Findings
- L9 Lactobacillus reduced total lung fibrosis scores by 30% in aging mice over nine months
- Collagen fiber accumulation dropped 40%, with the key Col-I protein reduced by 59%
- Mechanism runs through SASP cytokines → JNK pathway → HSF1 → HSP47 → collagen synthesis suppression
- L9 strain was originally identified in centenarians, suggesting a longevity-microbiome connection
- Effect was entirely due to reduced collagen production, not increased breakdown enzymes
Methodology
This is a research summary reporting on a peer-reviewed study published in Aging Cell, a credible high-impact journal. Evidence is based on mouse aging models (15–24 months) supplemented with bulk RNA sequencing of human lung samples. The causal chain is mechanistically detailed, strengthening internal validity.
Study Limitations
All intervention data comes from mice; human trials are needed before clinical recommendations can be made. The article content was truncated, so findings related to SASP cytokine reductions are incompletely reported. The specific gut metabolites responsible for the observed systemic effects have not yet been identified.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.